HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamide

a TGF-beta type I receptor kinase activity inhibitor
Also Known As:
SB 431542; SB-431542; SB431542
Networked: 59 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Wu, Kwan-Dun: 2 articles (01/2015 - 01/2013)
2. Lai, Chun-Fu: 2 articles (01/2015 - 01/2013)
3. Lin, Shuei-Liong: 2 articles (01/2015 - 01/2013)
4. Chen, Yung-Ming: 2 articles (01/2015 - 01/2013)
5. Chiang, Wen-Chih: 2 articles (01/2015 - 01/2013)
6. Miao, Zhi-Feng: 2 articles (04/2014 - 09/2010)
7. Glick, Adam B: 2 articles (04/2014 - 06/2011)
8. Xu, Hui-Mian: 2 articles (04/2014 - 09/2010)
9. Okumura, Meinoshin: 2 articles (11/2013 - 08/2013)
10. Funaki, Soichiro: 2 articles (11/2013 - 08/2013)

Related Diseases

1. Prostatic Neoplasms (Prostate Cancer)
2. Neoplasms (Cancer)
3. Carcinoma (Carcinomatosis)
4. Neoplasm Metastasis (Metastasis)
5. Fibrosis (Cirrhosis)

Related Drugs and Biologics

1. Transforming Growth Factor beta (TGF-beta)
2. Phosphotransferases (Kinase)
3. Activins (Activin)
4. Transforming Growth Factors (Transforming Growth Factor)
5. Transforming Growth Factor beta1 (TGF beta 1)
6. Collagen
7. Carbon Monoxide
8. Neutralizing Antibodies
9. Transforming Growth Factor beta Receptors (TGF beta Receptors)
10. Messenger RNA (mRNA)

Related Therapies and Procedures

1. Castration
2. Filtering Surgery
3. Therapeutics